WO2008152444A3 - Foamable waterless compositions with modulating agents - Google Patents
Foamable waterless compositions with modulating agents Download PDFInfo
- Publication number
- WO2008152444A3 WO2008152444A3 PCT/IB2007/004628 IB2007004628W WO2008152444A3 WO 2008152444 A3 WO2008152444 A3 WO 2008152444A3 IB 2007004628 W IB2007004628 W IB 2007004628W WO 2008152444 A3 WO2008152444 A3 WO 2008152444A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- modulating agents
- foam
- waterless
- cosmetic
- waterless compositions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
- A61K9/122—Foams; Dry foams
Abstract
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP07874548A EP2097065A2 (en) | 2006-11-29 | 2007-11-29 | Foamable waterless compositions with modulating agents |
AU2007355106A AU2007355106A1 (en) | 2006-11-29 | 2007-11-29 | Foamable waterless compositions with modulating agents |
IL198688A IL198688A (en) | 2006-11-29 | 2009-05-11 | Composition with modulating agents |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US86162006P | 2006-11-29 | 2006-11-29 | |
US60/861,620 | 2006-11-29 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2008152444A2 WO2008152444A2 (en) | 2008-12-18 |
WO2008152444A3 true WO2008152444A3 (en) | 2009-06-18 |
Family
ID=40130252
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB2007/004628 WO2008152444A2 (en) | 2006-11-29 | 2007-11-29 | Foamable waterless compositions with modulating agents |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP2097065A2 (en) |
AU (1) | AU2007355106A1 (en) |
IL (1) | IL198688A (en) |
WO (1) | WO2008152444A2 (en) |
Cited By (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8362091B2 (en) | 2003-08-04 | 2013-01-29 | Foamix Ltd. | Foamable vehicle and pharmaceutical compositions thereof |
US8435498B2 (en) | 2002-10-25 | 2013-05-07 | Foamix Ltd. | Penetrating pharmaceutical foam |
US8486375B2 (en) | 2003-04-28 | 2013-07-16 | Foamix Ltd. | Foamable compositions |
US8512718B2 (en) | 2000-07-03 | 2013-08-20 | Foamix Ltd. | Pharmaceutical composition for topical application |
US8518378B2 (en) | 2003-08-04 | 2013-08-27 | Foamix Ltd. | Oleaginous pharmaceutical and cosmetic foam |
US8618081B2 (en) | 2009-10-02 | 2013-12-31 | Foamix Ltd. | Compositions, gels and foams with rheology modulators and uses thereof |
US8840869B2 (en) | 2002-10-25 | 2014-09-23 | Foamix Ltd. | Body cavity foams |
US8900554B2 (en) | 2002-10-25 | 2014-12-02 | Foamix Pharmaceuticals Ltd. | Foamable composition and uses thereof |
US9072667B2 (en) | 2009-07-29 | 2015-07-07 | Foamix Pharmaceuticals Ltd. | Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses |
US9101662B2 (en) | 2003-08-04 | 2015-08-11 | Foamix Pharmaceuticals Ltd. | Compositions with modulating agents |
US9161916B2 (en) | 2007-12-07 | 2015-10-20 | Foamix Pharmaceuticals Ltd. | Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof |
US9211259B2 (en) | 2002-11-29 | 2015-12-15 | Foamix Pharmaceuticals Ltd. | Antibiotic kit and composition and uses thereof |
US9248136B2 (en) | 2011-11-23 | 2016-02-02 | Therapeuticsmd, Inc. | Transdermal hormone replacement therapies |
US9265725B2 (en) | 2002-10-25 | 2016-02-23 | Foamix Pharmaceuticals Ltd. | Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof |
US9320705B2 (en) | 2002-10-25 | 2016-04-26 | Foamix Pharmaceuticals Ltd. | Sensation modifying topical composition foam |
US9439857B2 (en) | 2007-11-30 | 2016-09-13 | Foamix Pharmaceuticals Ltd. | Foam containing benzoyl peroxide |
US9539208B2 (en) | 2002-10-25 | 2017-01-10 | Foamix Pharmaceuticals Ltd. | Foam prepared from nanoemulsions and uses |
US9572775B2 (en) | 2009-07-29 | 2017-02-21 | Foamix Pharmaceuticals Ltd. | Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses |
WO2019175290A1 (en) | 2018-03-13 | 2019-09-19 | Beckley Canopy Therapeutics Limited | Cannabis or cannabis derived compositions for promoting cessation of chemical dependence |
Families Citing this family (71)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8486376B2 (en) | 2002-10-25 | 2013-07-16 | Foamix Ltd. | Moisturizing foam containing lanolin |
US10117812B2 (en) | 2002-10-25 | 2018-11-06 | Foamix Pharmaceuticals Ltd. | Foamable composition combining a polar solvent and a hydrophobic carrier |
US9668972B2 (en) | 2002-10-25 | 2017-06-06 | Foamix Pharmaceuticals Ltd. | Nonsteroidal immunomodulating kit and composition and uses thereof |
BRPI0406905B8 (en) | 2003-01-24 | 2021-05-25 | Connetics Australia Pty Ltd | topical dispensing composition in a pressurized container |
US8486374B2 (en) | 2003-08-04 | 2013-07-16 | Foamix Ltd. | Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses |
WO2006100154A1 (en) | 2005-03-24 | 2006-09-28 | Nolabs Ab | Cosmetic treatment with nitric oxide, device for performing said treatment and manufacturing method therefor |
US20080260655A1 (en) | 2006-11-14 | 2008-10-23 | Dov Tamarkin | Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses |
US8636982B2 (en) | 2007-08-07 | 2014-01-28 | Foamix Ltd. | Wax foamable vehicle and pharmaceutical compositions thereof |
WO2010041141A2 (en) | 2008-10-07 | 2010-04-15 | Foamix Ltd. | Oil-based foamable carriers and formulations |
CA2712120A1 (en) | 2008-01-14 | 2009-07-23 | Foamix Ltd. | Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses |
WO2010085589A2 (en) | 2009-01-22 | 2010-07-29 | G&H Brands Llc | Desensitizing drug product |
WO2010096868A1 (en) | 2009-02-25 | 2010-09-02 | Stiefel Research Australia Pty Ltd | Topical foam composition |
WO2010125470A2 (en) | 2009-04-28 | 2010-11-04 | Foamix Ltd. | Foamable vehicle and pharmaceutical compositions comprising aprotic polar solvents and uses thereof |
WO2010130028A1 (en) * | 2009-05-15 | 2010-11-18 | bioCEPTA Corporation | Compositions suitable for the topical treatment of fungal infections of the skin and nails |
WO2011022680A2 (en) | 2009-08-21 | 2011-02-24 | Novan, Inc. | Wound dressings, methods of using the same and methods of forming the same |
BR112012003792B1 (en) | 2009-08-21 | 2020-05-19 | Novan Inc | topical composition, and, use of topical composition |
US9849142B2 (en) | 2009-10-02 | 2017-12-26 | Foamix Pharmaceuticals Ltd. | Methods for accelerated return of skin integrity and for the treatment of impetigo |
WO2011121062A1 (en) | 2010-03-31 | 2011-10-06 | Helmut Vockner | Composition for the treatment of periodontitis and other inflammatory infectious diseases |
WO2011133217A1 (en) * | 2010-04-21 | 2011-10-27 | Pharmacline, Llc | Topical drug delivery system with dual carriers |
AU2011264198B2 (en) | 2010-06-11 | 2015-04-09 | Leo Pharma A/S | A pharmaceutical spray composition comprising a vitamin D analogue and a corticosteroid |
US8357422B2 (en) | 2010-07-02 | 2013-01-22 | Rbc Life Sciences, Inc. | Dietary supplement |
US8809307B2 (en) | 2010-11-22 | 2014-08-19 | Dow Pharmaceutical Sciences, Inc. | Pharmaceutical formulations containing corticosteroids for topical administration |
US20180243420A1 (en) | 2010-11-22 | 2018-08-30 | Dow Pharmaceutical Sciences, Inc. | Pharmaceutical formulations containing corticosteroids for topical administration |
RU2734128C2 (en) * | 2010-12-16 | 2020-10-13 | Плэтформ Брайтворкс Ту,Лтд | Pharmaceutical preparations of azoles for parenteral administration and methods for preparing and using them for treating diseases which are sensitive to azole compounds |
US8952057B2 (en) | 2011-01-11 | 2015-02-10 | Jr Chem, Llc | Compositions for anorectal use and methods for treating anorectal disorders |
EP2672962B1 (en) * | 2011-02-11 | 2015-03-25 | Moberg Pharma AB | Novel antifungal composition |
DK3238709T3 (en) | 2011-04-28 | 2020-09-28 | Platform Brightworks Two Ltd | IMPROVED PARENTERAL FORMULATIONS OF LIPOFILE PHARMACEUTICALS AND METHODS FOR THE PREPARATION AND USE OF THE SAME |
ES2804263T3 (en) | 2011-07-05 | 2021-02-05 | Novan Inc | Topical compositions |
WO2013006613A1 (en) | 2011-07-05 | 2013-01-10 | Novan, Inc. | Methods of manufacturing topical compositions and apparatus for same |
US9301920B2 (en) | 2012-06-18 | 2016-04-05 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
ES2861439T3 (en) | 2012-03-14 | 2021-10-06 | Novan Inc | Pharmaceutical compositions releasing nitric oxide |
US20130338122A1 (en) | 2012-06-18 | 2013-12-19 | Therapeuticsmd, Inc. | Transdermal hormone replacement therapies |
US10806740B2 (en) | 2012-06-18 | 2020-10-20 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
US10806697B2 (en) | 2012-12-21 | 2020-10-20 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US20150196640A1 (en) | 2012-06-18 | 2015-07-16 | Therapeuticsmd, Inc. | Progesterone formulations having a desirable pk profile |
TW201410244A (en) * | 2012-08-13 | 2014-03-16 | Teva Pharma | Laquinimod for treatment of GABA mediated disorders |
US10568891B2 (en) | 2012-12-21 | 2020-02-25 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US10537581B2 (en) | 2012-12-21 | 2020-01-21 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US10471072B2 (en) | 2012-12-21 | 2019-11-12 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US9180091B2 (en) | 2012-12-21 | 2015-11-10 | Therapeuticsmd, Inc. | Soluble estradiol capsule for vaginal insertion |
US11266661B2 (en) | 2012-12-21 | 2022-03-08 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US11246875B2 (en) | 2012-12-21 | 2022-02-15 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US9855211B2 (en) | 2013-02-28 | 2018-01-02 | Novan, Inc. | Topical compositions and methods of using the same |
ES2836132T3 (en) | 2013-08-08 | 2021-06-24 | Novan Inc | Topical compositions and methods of using them |
US10206932B2 (en) | 2014-05-22 | 2019-02-19 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
ES2759224T3 (en) * | 2014-06-12 | 2020-05-08 | Ceva Sante Animale | Composite foam pheromone compositions |
BR112017000456B1 (en) | 2014-07-11 | 2022-12-13 | Novan, Inc | USE OF A NITRIC OXIDE-RELEASING ACTIVE PHARMACEUTICAL INGREDIENT AND TOPICAL COMPOSITION FOR TREATMENT AND/OR PREVENTION OF A VIRAL INFECTION |
US10322082B2 (en) | 2014-07-11 | 2019-06-18 | Novan, Inc. | Topical antiviral compositions and methods of using the same |
US10925689B2 (en) | 2014-07-14 | 2021-02-23 | Novan, Inc. | Nitric oxide releasing nail coating compositions, nitric oxide releasing nail coatings, and methods of using the same |
MX2016013693A (en) | 2014-07-29 | 2017-10-31 | Therapeuticsmd Inc | Transdermal cream. |
CA2919733A1 (en) | 2014-08-08 | 2016-02-08 | Novan, Inc. | Topical compositions and methods of using the same |
WO2016115639A1 (en) | 2015-01-23 | 2016-07-28 | Biocidium Biopharmaceuticals Inc. | Anti-bacterial compositions |
JP6997624B2 (en) | 2015-06-18 | 2022-01-17 | ボシュ ヘルス ユーエス,エルエルシー. | Topical composition containing corticosteroids and retinoids for the treatment of psoriasis |
US10328087B2 (en) | 2015-07-23 | 2019-06-25 | Therapeuticsmd, Inc. | Formulations for solubilizing hormones |
US10849864B2 (en) | 2015-07-28 | 2020-12-01 | Novan, Inc. | Combinations and methods for the treatment and/or prevention of fungal infections |
JP6864001B2 (en) | 2015-11-03 | 2021-04-21 | ゾエティス・サービシーズ・エルエルシー | Sol-gel polymer compositions and their use |
CN105424884B (en) * | 2015-11-18 | 2017-04-05 | 中国海洋石油总公司 | A kind of detection method of poly- table binary composite oil-displacing system concentration of component |
EP3423100A4 (en) | 2016-03-02 | 2019-10-16 | Novan, Inc. | Compositions for treating inflammation and methods of treating the same |
US10286077B2 (en) | 2016-04-01 | 2019-05-14 | Therapeuticsmd, Inc. | Steroid hormone compositions in medium chain oils |
AU2017239645A1 (en) | 2016-04-01 | 2018-10-18 | Therapeuticsmd, Inc. | Steroid hormone pharmaceutical composition |
KR102426006B1 (en) | 2016-04-13 | 2022-07-29 | 노반, 인크. | Compositions, systems, kits, and methods for treating infections |
GB201607814D0 (en) | 2016-05-04 | 2016-06-15 | 5D Health Prot Group Ltd | Anti-microbial compositions |
MX2020012139A (en) | 2016-09-08 | 2021-01-29 | Vyne Pharmaceuticals Inc | Compositions and methods for treating rosacea and acne. |
US20180103680A1 (en) * | 2016-10-18 | 2018-04-19 | Altria Client Services Llc | Methods and systems for improving stability of the pre-vapor formulation of an e-vaping device |
US20180103681A1 (en) * | 2016-10-18 | 2018-04-19 | Altria Client Services Llc | Methods and systems for increasing stability of the pre-vapor formulation of an e-vaping device |
WO2019169221A1 (en) | 2018-03-01 | 2019-09-06 | Novan, Inc. | Nitric oxide releasing suppositories and methods of use thereof |
CN108949296B (en) * | 2018-08-15 | 2021-11-05 | 江苏四新界面剂科技有限公司 | Monocrystalline silicon cutting surfactant |
GB201813876D0 (en) | 2018-08-24 | 2018-10-10 | Antibiotx As | Treatment |
WO2020089467A1 (en) | 2018-11-02 | 2020-05-07 | UNION therapeutics A/S | Dosage regimen |
JP2022506799A (en) | 2018-11-02 | 2022-01-17 | ユニオン セラピューティクス エー/エス | Halogenated salicylanilide for treating the symptoms of dermatitis |
DE102022116721A1 (en) | 2022-07-05 | 2024-01-11 | Paul Hartmann Ag | Absorbent incontinence article as a disposable disposable product and method for producing the incontinence article |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB933486A (en) * | 1960-10-26 | 1963-08-08 | Vantorex Ltd | Improvements in or relating to aerosol foams |
WO1991011991A1 (en) * | 1990-02-09 | 1991-08-22 | Kabi Pharmacia Ab | Foamable composition for pharmaceutical use, use thereof and method of treatment |
US5536743A (en) * | 1988-01-15 | 1996-07-16 | Curatek Pharmaceuticals Limited Partnership | Intravaginal treatment of vaginal infections with buffered metronidazole compositions |
WO2008075207A2 (en) * | 2006-04-04 | 2008-06-26 | Foamix Ltd. | Anti-infection augmentation foamable compositions and kit and uses thereof |
-
2007
- 2007-11-29 EP EP07874548A patent/EP2097065A2/en not_active Withdrawn
- 2007-11-29 AU AU2007355106A patent/AU2007355106A1/en not_active Abandoned
- 2007-11-29 WO PCT/IB2007/004628 patent/WO2008152444A2/en active Application Filing
-
2009
- 2009-05-11 IL IL198688A patent/IL198688A/en not_active IP Right Cessation
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB933486A (en) * | 1960-10-26 | 1963-08-08 | Vantorex Ltd | Improvements in or relating to aerosol foams |
US5536743A (en) * | 1988-01-15 | 1996-07-16 | Curatek Pharmaceuticals Limited Partnership | Intravaginal treatment of vaginal infections with buffered metronidazole compositions |
WO1991011991A1 (en) * | 1990-02-09 | 1991-08-22 | Kabi Pharmacia Ab | Foamable composition for pharmaceutical use, use thereof and method of treatment |
WO2008075207A2 (en) * | 2006-04-04 | 2008-06-26 | Foamix Ltd. | Anti-infection augmentation foamable compositions and kit and uses thereof |
Cited By (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8512718B2 (en) | 2000-07-03 | 2013-08-20 | Foamix Ltd. | Pharmaceutical composition for topical application |
US8435498B2 (en) | 2002-10-25 | 2013-05-07 | Foamix Ltd. | Penetrating pharmaceutical foam |
US9539208B2 (en) | 2002-10-25 | 2017-01-10 | Foamix Pharmaceuticals Ltd. | Foam prepared from nanoemulsions and uses |
US9492412B2 (en) | 2002-10-25 | 2016-11-15 | Foamix Pharmaceuticals Ltd. | Penetrating pharmaceutical foam |
US9320705B2 (en) | 2002-10-25 | 2016-04-26 | Foamix Pharmaceuticals Ltd. | Sensation modifying topical composition foam |
US8840869B2 (en) | 2002-10-25 | 2014-09-23 | Foamix Ltd. | Body cavity foams |
US9265725B2 (en) | 2002-10-25 | 2016-02-23 | Foamix Pharmaceuticals Ltd. | Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof |
US8900554B2 (en) | 2002-10-25 | 2014-12-02 | Foamix Pharmaceuticals Ltd. | Foamable composition and uses thereof |
US9211259B2 (en) | 2002-11-29 | 2015-12-15 | Foamix Pharmaceuticals Ltd. | Antibiotic kit and composition and uses thereof |
US8486375B2 (en) | 2003-04-28 | 2013-07-16 | Foamix Ltd. | Foamable compositions |
US8703105B2 (en) | 2003-08-04 | 2014-04-22 | Foamix Ltd. | Oleaginous pharmaceutical and cosmetic foam |
US8362091B2 (en) | 2003-08-04 | 2013-01-29 | Foamix Ltd. | Foamable vehicle and pharmaceutical compositions thereof |
US9050253B2 (en) | 2003-08-04 | 2015-06-09 | Foamix Pharmaceuticals Ltd. | Oleaginous pharmaceutical and cosmetic foam |
US8518378B2 (en) | 2003-08-04 | 2013-08-27 | Foamix Ltd. | Oleaginous pharmaceutical and cosmetic foam |
US9101662B2 (en) | 2003-08-04 | 2015-08-11 | Foamix Pharmaceuticals Ltd. | Compositions with modulating agents |
US9439857B2 (en) | 2007-11-30 | 2016-09-13 | Foamix Pharmaceuticals Ltd. | Foam containing benzoyl peroxide |
US9161916B2 (en) | 2007-12-07 | 2015-10-20 | Foamix Pharmaceuticals Ltd. | Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof |
US9072667B2 (en) | 2009-07-29 | 2015-07-07 | Foamix Pharmaceuticals Ltd. | Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses |
US9572775B2 (en) | 2009-07-29 | 2017-02-21 | Foamix Pharmaceuticals Ltd. | Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses |
US8945516B2 (en) | 2009-10-02 | 2015-02-03 | Foamix Pharmaceuticals Ltd. | Surfactant-free water-free foamable compositions, breakable foams and gels and their uses |
US8865139B1 (en) | 2009-10-02 | 2014-10-21 | Foamix Pharmaceuticals Ltd. | Topical tetracycline compositions |
US8992896B2 (en) | 2009-10-02 | 2015-03-31 | Foamix Pharmaceuticals Ltd. | Topical tetracycline compositions |
US8618081B2 (en) | 2009-10-02 | 2013-12-31 | Foamix Ltd. | Compositions, gels and foams with rheology modulators and uses thereof |
US9248136B2 (en) | 2011-11-23 | 2016-02-02 | Therapeuticsmd, Inc. | Transdermal hormone replacement therapies |
WO2019175290A1 (en) | 2018-03-13 | 2019-09-19 | Beckley Canopy Therapeutics Limited | Cannabis or cannabis derived compositions for promoting cessation of chemical dependence |
Also Published As
Publication number | Publication date |
---|---|
EP2097065A2 (en) | 2009-09-09 |
IL198688A (en) | 2015-06-30 |
WO2008152444A2 (en) | 2008-12-18 |
IL198688A0 (en) | 2010-02-17 |
AU2007355106A1 (en) | 2008-12-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2008152444A3 (en) | Foamable waterless compositions with modulating agents | |
WO2007103719A3 (en) | MODULATORS OF 11-β HYDROXYL STEROID DEHYDROGENASE TYPE 1, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USING THE SAME | |
WO2007084314A3 (en) | MODULATORS OF 11-ß HYDROXYL STEROID DEHYDROGENASE TYPE 1, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USING THE SAME | |
WO2007137066A3 (en) | HETEROCYCLIC INHIBITORS OF 11-β HYDROXYL STEROID DEHYDROGENASE TYPE I AND METHODS OF USING THE SAME | |
WO2007067504A3 (en) | Lactam compounds and methods of using the same | |
WO2007038138A3 (en) | Amido compounds and their use as pharmaceuticals | |
WO2006069998A3 (en) | Glycopyrrolate in cosmetic preparations | |
WO2007081579A3 (en) | Foam/spray producing compositions and dispensing system therefor | |
WO2009120365A3 (en) | Methods and compositions for the delivery of agents | |
WO2007064931A3 (en) | Substituted 4-amino-pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis | |
WO2006083630A3 (en) | Diiodomethyl-p-tolylsulfone as a particulate dispersion in a liquid solvent in combination with an anti-dandruff active | |
EP2070509A3 (en) | The use of Myrica gale oil | |
WO2006002361A3 (en) | 2-methylpropanamides and their use as pharmaceuticals | |
WO2011009436A3 (en) | Method for developing a liquid composition to be applied to the skin as a foam and a composition that can be applied topically | |
WO2006004741A3 (en) | 3-aminocyclopentanecarboxamides as modulators of chemokine receptors | |
WO2006012227A3 (en) | Amido compounds and their use as pharmaceuticals | |
WO2007111806A3 (en) | Cyclopentane heptanoic acid compounds for reducing body fat | |
WO2007073486A3 (en) | Methods and compositions for delivering active agents with enhanced pharmacological properties | |
WO2006044362A3 (en) | N-sulfonylpiperidine cannabinoid receptor 1 antagonists | |
WO2008009379A3 (en) | Active ingredient combinations having insecticide and acaricide properties | |
WO2006004684A3 (en) | 3-aminocyclopentanecarboxamides as modulators of chemokine receptors | |
MX2009006140A (en) | Microencapsulated delivery vehicle having an aqueous core. | |
WO2008018796A3 (en) | Viscoelastic aqueous gels comprising microspheres | |
WO2007133751A3 (en) | Base-stabilized polyorthoester formulations | |
WO2006099187A3 (en) | Benzoyl peroxide compositions and methods of use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 2007874548 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 198688 Country of ref document: IL |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2007355106 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2403/KOLNP/2009 Country of ref document: IN |
|
ENP | Entry into the national phase |
Ref document number: 2007355106 Country of ref document: AU Date of ref document: 20071129 Kind code of ref document: A |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 07874548 Country of ref document: EP Kind code of ref document: A2 |